Cetera Investment Advisers’s Autolus Therapeutics AUTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Buy |
617,172
+92,300
| +18% | +$210K | ﹤0.01% | 2105 |
|
|
2025
Q1 | $814K | Buy |
524,872
+168,650
| +47% | +$261K | ﹤0.01% | 2434 |
|
|
2024
Q4 | $837K | Buy |
356,222
+224,222
| +170% | +$527K | ﹤0.01% | 2285 |
|
|
2024
Q3 | $479K | Sell |
132,000
-2,500
| -2% | -$9.08K | ﹤0.01% | 2683 |
|
|
2024
Q2 | $468K | Buy |
134,500
+2,719
| +2% | +$9.46K | ﹤0.01% | 2646 |
|
|
2024
Q1 | $841K | Buy |
131,781
+281
| +0.2% | +$1.79K | ﹤0.01% | 2212 |
|
|
2023
Q4 | $847K | Sell |
131,500
-2,500
| -2% | -$16.1K | 0.01% | 1198 |
|
|
2023
Q3 | $312K | Sell |
134,000
-1,200
| -0.9% | -$2.8K | ﹤0.01% | 1699 |
|
|
2023
Q2 | $322K | Sell |
135,200
-6,400
| -5% | -$15.2K | ﹤0.01% | 1695 |
|
|
2023
Q1 | $261K | Buy |
141,600
+4,000
| +3% | +$7.36K | ﹤0.01% | 1787 |
|
|
2022
Q4 | $261K | Buy |
137,600
+2,200
| +2% | +$4.18K | ﹤0.01% | 1743 |
|
|
2022
Q3 | $290K | Buy |
135,400
+8,400
| +7% | +$18K | 0.01% | 1285 |
|
|
2022
Q2 | $359K | Buy |
127,000
+2,700
| +2% | +$7.63K | 0.01% | 1296 |
|
|
2022
Q1 | $518K | Buy |
124,300
+9,550
| +8% | +$39.8K | 0.01% | 1127 |
|
|
2021
Q4 | $596K | Buy |
114,750
+9,650
| +9% | +$50.1K | 0.01% | 1081 |
|
|
2021
Q3 | $688K | Buy |
+105,100
| New | +$688K | 0.01% | 944 |
|